Connection

David Mahvi to Lymphocytes, Tumor-Infiltrating

Back to Details
This is a "connection" page, showing publications David Mahvi has written about Lymphocytes, Tumor-Infiltrating.
David Mahvi
Connection Strength
0.144
Lymphocytes, Tumor-Infiltrating
  1. Pilot trial of the hu14.18-IL2 immunocytokine in patients with completely resectable recurrent stage III or stage IV melanoma. Cancer Immunol Immunother. 2018 Oct; 67(10):1647-1658.
    View in: PubMed
    Score: 0.144
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.